Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 19, 2022

SELL
$4.51 - $16.22 $2,769 - $9,959
-614 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$10.35 - $31.18 $6,044 - $18,209
584 Added 1946.67%
614 $9,000
Q3 2021

Oct 15, 2021

BUY
$26.21 - $48.74 $786 - $1,462
30 New
30 $1,000
Q1 2020

May 05, 2020

SELL
$36.13 - $69.2 $281,055 - $538,306
-7,779 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$38.2 - $54.75 $87,898 - $125,979
2,301 Added 42.0%
7,779 $379,000
Q3 2019

Nov 14, 2019

SELL
$48.86 - $66.12 $113,355 - $153,398
-2,320 Reduced 29.75%
5,478 $301,000
Q2 2019

Aug 07, 2019

BUY
$41.42 - $57.05 $64,739 - $89,169
1,563 Added 25.07%
7,798 $389,000
Q1 2019

May 14, 2019

SELL
$52.79 - $68.43 $13,250 - $17,175
-251 Reduced 3.87%
6,235 $352,000
Q4 2018

Feb 14, 2019

SELL
$55.94 - $81.46 $24,277 - $35,353
-434 Reduced 6.27%
6,486 $414,000
Q3 2018

Nov 14, 2018

SELL
$56.75 - $90.65 $142,556 - $227,712
-2,512 Reduced 26.63%
6,920 $562,000
Q2 2018

Aug 14, 2018

BUY
$36.43 - $64.45 $343,607 - $607,892
9,432 New
9,432 $602,000

Others Institutions Holding TRHC

About Tabula Rasa HealthCare, Inc.


  • Ticker TRHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 26,251,000
  • Description
  • Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication thera...
More about TRHC
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.